Snell & Wilmer has announced that Jason Gersting has joined the firm as a partner in its intellectual property practice group based in Orange County, California. According to the firm, Gersting’s practice focuses on the strategic management of intellectual property portfolios in the life science, biotech, and medtech sectors. He has a wide array of experience advising clients in various technology fields including cell therapy, immune management therapy, gene therapy, regenerative medicine, biotech, clean tech, and medical devices. Gersting’s addition to Snell & Wilmer comes from his former position at Knobbe Martens.
For more details, the official announcement from Snell & Wilmer can be found here. Further context on this development was also reported by Bloomberg Law.